Acumen Pharmaceuticals, Inc. (ABOS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -100% | - | - |
| Cost of Goods Sold | 46K | 0 | 0 | 0 | 0 | 44K | 0 | 0 | 0 | 39K | 473K | 9.13M | 8.71M | 10.75M | 8.31M | 7.32M | 5.99M | 5.67M | 1.8M | 2.25M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -46K | 0 | 0 | 0 | 0 | -44K | 0 | 0 | 0 | -39K | -473K | -9.13M | -8.71M | -10.75M | -8.31M | -7.32M | -5.99M | -5.67M | -1.8M | -2.25M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | - | - | -12.82% | 100% | 100% | 100% | 99.64% | 94.31% | -24.75% | -45.58% | -89.42% | -361.61% | -224.8% | - | -713.92% | - | - |
| Operating Expenses | 21.1M | 25.2M | 26.51M | 41.75M | 30.37M | 39.55M | 32.27M | 24.38M | 17.77M | 18.45M | 15.57M | 4.34M | 4.42M | 3.5M | 3.06M | 3.09M | 3.22M | 2.74M | 2.13M | 1.19M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.62M | 4.67M | 4.54M | 4.63M | 5.1M | 5.03M | 5.02M | 4.85M | 5.33M | 5.15M | 4.86M | 4.34M | 4.42M | 3.5M | 3.06M | 3.09M | 3.22M | 2.74M | 2.13M | 1.19M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 16.48M | 20.53M | 21.97M | 37.13M | 25.27M | 34.57M | 27.25M | 19.53M | 12.45M | 13.29M | 11.18M | 9.13M | 8.71M | 10.75M | 8.31M | 7.32M | 5.99M | 5.67M | 1.8M | 2.25M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -473K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -21.15M | -25.2M | -26.51M | -41.75M | -30.37M | -39.6M | -32.27M | -24.38M | -17.77M | -18.49M | -16.04M | -13.48M | -13.13M | -14.25M | -11.37M | -10.41M | -9.21M | -8.41M | -3.94M | -3.44M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 30.36% | 36.36% | 17.83% | -71.24% | -70.87% | -114.2% | -101.17% | -80.89% | -35.32% | -29.74% | -41.05% | -29.46% | -42.68% | -69.32% | -188.97% | -202.56% | -142.71% | -527.52% | - | - |
| EBITDA | -21.1M | -25.15M | -26.47M | -41.7M | -30.32M | -39.55M | -32.22M | -24.34M | -17.73M | -18.45M | -16.03M | -13.46M | -13.12M | -14.24M | -11.36M | -10.4M | -9.2M | -8.41M | -3.93M | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 30.41% | 36.4% | 17.86% | -71.36% | -71.04% | -114.41% | -101.05% | -80.76% | -35.13% | -29.58% | -41.06% | -29.39% | -42.59% | -69.23% | -188.74% | - | -142.6% | - | - | - |
| D&A (Non-Cash Add-back) | 46K | 45K | 47K | 47K | 45K | 44K | 45K | 45K | 44K | 39K | 13K | 15K | 14K | 12K | 10K | 6K | 4K | 3K | 333 | 3.44M |
| EBIT | -21.15M | -24.05M | -25.38M | -39.9M | -27.77M | -36.12M | -28.74M | -19.53M | -13.87M | -15.92M | -16.04M | -13.48M | -13.13M | -14.25M | -11.37M | -10.41M | -9.21M | -8.41M | -3.94M | -3.44M |
| Net Interest Income | -5K | 235K | 571K | 969K | 1.45M | 1.96M | 2.48M | 2.81M | 3M | 3.37M | 3.12M | 1.88M | 1.83M | 1.39M | 663K | 260K | 76K | 39K | 14K | 4K |
| Interest Income | 1.06M | 1.32M | 1.64M | 2.02M | 2.47M | 2.99M | 3.5M | 3.82M | 4M | 3.95M | 3.12M | 1.88M | 1.83M | 1.39M | 663K | 260K | 76K | 39K | 37K | 4K |
| Interest Expense | 1.07M | 1.09M | 1.07M | 1.05M | 1.02M | 1.04M | 1.03M | 1M | 1M | 581K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23K | 0 |
| Other Income/Expense | 412K | 61K | 62K | 800K | 1.57M | 2.44M | 2.5M | 3.84M | 2.9M | 1.99M | 3.08M | 1.87M | 1.83M | 1.38M | 661K | 260K | 77K | 66K | 33K | -57.92M |
| Pretax Income | -20.74M | -25.14M | -26.45M | -40.95M | -28.8M | -37.15M | -29.77M | -20.54M | -14.87M | -16.5M | -12.96M | -11.61M | -11.31M | -12.87M | -10.71M | -10.15M | -9.13M | -8.35M | -3.9M | -61.36M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -20.74M | -25.14M | -26.45M | -40.95M | -28.8M | -37.15M | -29.77M | -20.54M | -14.87M | -16.5M | -12.96M | -11.61M | -11.31M | -12.87M | -10.71M | -10.15M | -9.13M | -8.35M | -3.9M | -61.36M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 27.99% | 32.34% | 11.13% | -99.4% | -93.61% | -125.22% | -129.72% | -76.89% | -31.54% | -28.22% | -20.98% | -14.37% | -23.86% | -54.1% | -174.47% | 83.46% | 66.19% | -1005.83% | - | - |
| Net Income (Continuing) | -20.74M | -25.14M | -26.45M | -40.95M | -28.8M | -37.15M | -29.77M | -20.54M | -14.87M | -16.5M | -12.96M | -11.61M | -11.31M | -12.87M | -10.71M | -10.15M | -9.13M | -8.35M | -3.9M | -61.36M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.33 | -0.42 | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 | -0.34 | -0.25 | -0.28 | -0.24 | -0.28 | -0.23 | -0.34 | -0.25 | -0.24 | -0.22 | -0.22 | -0.10 | -1.59 |
| EPS Growth % | 31.25% | 32.26% | 12% | -100% | -92% | -121.43% | -108.33% | -21.43% | -8.7% | 17.65% | 4% | -16.67% | -4.55% | -54.55% | -150% | 84.91% | 69.86% | -733.33% | - | - |
| EPS (Basic) | -0.33 | -0.42 | -0.44 | -0.68 | -0.48 | -0.62 | -0.50 | -0.34 | -0.25 | -0.28 | -0.24 | -0.28 | -0.23 | -0.34 | -0.25 | -0.24 | -0.22 | -0.22 | -0.10 | -1.59 |
| Diluted Shares Outstanding | 63.22M | 60.56M | 60.57M | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 58.01M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M |
| Basic Shares Outstanding | 63.22M | 60.56M | 60.57M | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 57.91M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |